得一药房品牌怎么样 申请店铺

我要投票 得一药房在医疗器械行业中的票数:653 更新时间:2026-02-13
得一药房是哪个国家的品牌?「得一药房」是 上海得一大药房连锁有限公司 旗下著名品牌。该品牌发源于上海市,由创始人龚 * 燕在1956年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力得一药房品牌出海!将品牌入驻外推网,定制得一药房品牌推广信息,可以显著提高得一药房产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

得一药房怎么样

上海得一大药房连锁有限公司,秉承“贡献人类健康,提高生命质量”的企业使命,用规范高效的管理提高企业经营水平,用热情精心的服务回报社会。“得一”始终坚持“质量=生命”的企业座右铭,全力打造“守信誉、求品质、重服务”的企业品牌。

公司于2003年顺利通过国家食品药品监督管理局 GSP认证后,在2008年又通过了市局的GSP重新认证。半个世纪的发展,公司几经易名,但不变的是对医药健康事业的不懈追求。

药房坚持“问病卖药,买药问病;小病当参谋,大病当亲人。”的企业传统,精心操作,诚心相待,对顾客服务热心周到,并且开展多种多样的便民服务。

药房分布于全市各区,经营品种丰富,种类齐全,并根据不同的客户需求开设了类风关特色店、平价药房、参茸精品店、折扣店等特色店。在药房设有专区提供免费测血糖服务;在医保定点药房内设有顾客休息区,配备首席执业药师对客户进行指导用药;提供“健康包”特色服务,为顾客配备个性“家庭必备小药箱”及“旅游必备健康包”;清理、回收“家庭小药箱”;提供3公里内24小时送货上门服务。目前公司拥有近10万会员,提供会员优惠、会员日折扣、消费积分换礼等活动。另外,公司积极开展社会公益活动:进入社区,免费进行健康咨询活动,普及健康常识。

上海得一大药房有限公司上下一致,群策群力,共同策划公司的未来,对公司在今后的发展进行长远的规划:加快门店网点拓展;提高店员药学服务质量,指导百姓合理用药,提升公司的综合竞争力。


Shanghai Deyi pharmacy chain Co., Ltd. adheres to the corporate mission of "contributing to human health and improving the quality of life", improves the business level with standardized and efficient management, and rewards the society with warm and meticulous service. "Deyi" always adheres to the enterprise motto of "quality = life", and strives to build an enterprise brand of "keeping reputation, seeking quality and valuing service". The company successfully passed GSP certification of the State Food and Drug Administration in 2003, and then passed GSP re certification of the Municipal Bureau in 2008. With the development of half a century, the company has changed its name several times, but what remains unchanged is its unremitting pursuit of medical and health undertakings. The pharmacy insists on "asking for medicine, buying medicine and asking for disease; taking minor illness as advice and serious illness as relatives" The company has a tradition of careful operation, sincere treatment, warm and thoughtful customer service, and a variety of convenient services. Dispensaries are distributed in all districts of the city, with rich business varieties and complete varieties. According to different customer needs, they have set up characteristic stores like Fengguan specialty store, affordable pharmacy, Shenrong boutique store, discount store and so on. There is a special area in the pharmacy to provide free blood glucose measurement service; there is a rest area for customers in the designated pharmacy for medical insurance, equipped with the chief licensed pharmacist to guide the use of drugs for customers; there is a special service of "health package", equipped with personalized "family essential small medicine box" and "travel essential health package"; there is a cleaning and recycling of "family small medicine box"; there is a 24-hour delivery home service within 3 kilometers Business. At present, the company has nearly 100000 members, providing member discounts, member daily discounts, points for gifts and other activities. In addition, the company actively carries out social public welfare activities: enter the community, carry out free health consultation activities, and popularize health knowledge. Shanghai Deyi pharmacy Co., Ltd. plans the future of the company in a long-term way: accelerate the expansion of outlets; improve the pharmaceutical service quality of clerks, guide the people to use drugs reasonably, and improve the comprehensive competitiveness of the company.

本文链接: https://brand.waitui.com/7fe368ff2.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

热门中概股美股盘前多数下跌,理想汽车跌超1%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,京东、B站、腾讯音乐、理想汽车跌超1%,百度跌0.94%,蔚来跌0.79%,小鹏汽车跌0.77%,阿里巴巴跌0.74%,爱奇艺跌0.52%;网易涨近1%。

2小时前

翔鹭钨业:如钨精矿价格剧烈变化而钨制品价格未能同步变动,将对公司经营业绩产生影响

36氪获悉,翔鹭钨业公告,公司生产所需的钨精矿基本通过外购获得,公司产品的销售价格根据钨精矿价格变动情况相应调整,从而降低了原材料价格波动对公司经营业绩的影响,但如果未来钨精矿价格发生剧烈变化而钨制品价格未能同步变动,将会对公司主要产品的毛利率水平及经营业绩产生影响。

2小时前

中芯国际:存储器、BCD供不应求都在涨价

36氪获悉,中芯国际公告,在11月份业绩说明会上,有提到存储大周期对于产业和晶圆代工业的影响。在这样的市场环境下,公司凭借在BCD、模拟、存储、MCU、中高端显示驱动等细分领域中的技术储备与领先优势、客户的产品布局,在本轮行业发展周期中,仍能保持有利位置。公司将积极响应市场的紧急需求,推动2026年收入继续增长。价钱是一种供需的关系。中芯国际的存储器、BCD供不应求,都是在涨价的,友商部分成熟的产能不做了,市场上的供应量是在下降的。

2小时前

沪电股份:拟投资33亿元新建高端印制电路板生产项目

36氪获悉,沪电股份公告,公司于2026年2月11日召开的第八届董事会第十四次会议审议通过《关于新建高端印制电路板生产项目的议案》,同意投资新建“高端印制电路板生产项目”,生产高层数、高频高速、高密度互连、高通流PCB,以满足高速运算服务器、下一代高速网络交换机等对高端印制电路板的中长期增量需求。本项目总投资约为33亿元人民币,建成后预计年新增产能14万平方米高端印制电路板的生产规模,预计年新增营业收入30.5亿元人民币。

2小时前

引航生物递表港交所

36氪获悉,据港交所,苏州引航生物科技股份有限公司向港交所提交上市申请书,独家保荐人为华泰国际。

2小时前

本页详细列出关于得一药房的品牌信息,含品牌所属公司介绍,得一药房所处行业的品牌地位及优势。
咨询